Seeking Alpha

  Peregrine Pharmaceuticals Inc. - NASDAQ

11/26/2014, 12:54 PM ET
  • The Scientist | Send Message 24 May 2012

    PPHM: Bavituximab data looks good for lung CA. Works even better in breast CA than lung CA. P2 in breast CA showed CR of 24%. CR, not PR!
    Reply (5)
  • View all 5 replies
    • TruffelPig | Send Message 7 Jun 2012
      : Interesting data though - last year I nearly bought but thanks god not.......
    • TruffelPig | Send Message 7 Jun 2012
      : Will PPHM survive? If so, how long? Opinions please.
      PPHM vs. ETF Alternatives
      Company Description
      Peregrine Pharmaceuticals Inc is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for treatment & diagnosis of cancer. With its phosphatidylserine-targeting platform, it is pursuing two clinical programs in cancer.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States